Pentosan polysulfate sodium Pregnancy and Breastfeeding Warnings
Pentosan polysulfate sodium is also known as: Elmiron
Pentosan polysulfate sodium Pregnancy Warnings
Pentosan polysulfate sodium was studied in eight cases of medical abortion. A single 50 mg dose of pentosan polysulfate sodium was administered intravenously during mid trimester of pregnancy. Blood samples were obtained at 30 minutes from the mother and the fetus and hematologic values were compared with normal controls obtained under the same conditions. The mothers displayed a prolonged APTT, decreased factor Xa production and decreased factor V levels. Conversely, the fetuses displayed no hematologic laboratory abnormalities.
Pentosan polysulfate sodium has been assigned to pregnancy category B by the FDA. Animal studies have not revealed evidence of fetotoxicity. There are no controlled data in human pregnancy. Pentosan polysulfate sodium is only recommended for use during pregnancy when benefit outweighs risk.
Pentosan polysulfate sodium Breastfeeding Warnings
There are no data on the excretion of pentosan polysulfate sodium into breast milk. The manufacturer recommends that caution be used when administering pentosan polysulfate sodium to nursing women.
See Also...
- pentosan Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
